No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Nuclear Grading

(NOO-klee-er GRAY-ding)

Nuclear grading is a system pathologists use to score how abnormal the nuclei (the control centers) of tumor cells look under the microscope. In epithelioid mesothelioma, it combines two features, nuclear atypia (how irregular and enlarged the nuclei are) and mitotic count (how often the cells are dividing), into a grade that helps predict how aggressively the cancer will behave.

Origin

Formal nuclear grading for epithelioid mesothelioma was introduced in 2012 by Kadota and colleagues at Memorial Sloan Kettering, who showed that combining nuclear atypia and mitotic count produced a three-tier system strongly tied to survival. It was validated in larger cohorts in 2018 and is now incorporated into the World Health Organization classification of pleural tumors.

Significance in Asbestos Context

For someone diagnosed with epithelioid mesothelioma, the nuclear grade reported on a biopsy can meaningfully influence prognosis discussions, treatment intensity, and eligibility for clinical trials or aggressive surgery. A low-grade tumor may carry a median survival roughly twice that of a high-grade tumor, even when stage and other factors are similar. The grade also appears in pathology reports that become part of the medical record used to document the disease in a legal claim, so it is worth asking the pathologist whether nuclear grading was performed and what grade was assigned. Importantly, formal nuclear grading is currently validated only for epithelioid mesothelioma, not for sarcomatoid or biphasic subtypes.

Example Sentence

When the oncologist reviewed the pathology report, she noted that the nuclear grading came back as Grade I, which gave the family some cautious optimism about how the epithelioid mesothelioma might respond to treatment.

Epithelioid Mesothelioma, Mitotic Count, Nuclear Atypia, Histologic Subtype, Pathology Report, Ki-67 Index

Notes

  • Ask your oncologist or pathologist whether nuclear grading was reported, and if not, whether the original slides can be reviewed to assign a grade. This often requires a specific request to the pathology lab.
  • If your diagnosis is epithelioid mesothelioma, request that pathology be reviewed at a mesothelioma specialty center; nuclear grading is subtype-specific and benefits from experienced pathologists.
  • Preserve all pathology reports, immunohistochemistry results, and the original slides or paraffin blocks. These documents support both treatment decisions and legal claims and may be needed for second opinions or expert review.
  • Nuclear grade is one factor among many; ask how it combines with stage, blood markers, and your overall health to shape treatment options and prognosis.

In the research library

14 studies in our medical research library mention Nuclear Grading in the title or abstract. Among the most cited:

The journals that publish most on it: Modern Pathology (2), Diagnostics (2), Histopathology (1).

Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.